Overview of Tirzepatide (Dual GIP / GLP-1 Agonist) – 10mg Tirzepatide is a synthetic peptide engineered to interact with both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors in laboratory settings.
In research environments, it is utilized to examine dual incretin receptor activation, signaling cross-talk, and controlled metabolic pathway responses in isolated cellular systems.
Research Applications:
- Metabolic Pathway Analysis: Investigating the combined effect of GIP and GLP-1 receptor engagement in controlled assay environments.
- Receptor Pharmacology: Observing receptor binding, activation sequence, and downstream intracellular signaling behavior.
- Peptide Stability Profiling: Evaluating formulation stability and analytical consistency in biochemical testing workflows.
The Secra Labs Quality Guarantee This product has been synthesized to the highest research standards. Every batch of Secra Labs Tirzepatide undergoes rigorous independent HPLC and MS testing to ensure a minimum purity threshold of 99%, supporting reproducible metabolic and receptor-focused studies.
Disclaimer: This product is sold strictly for in-vitro laboratory research, development, and analytical purposes. It is not a drug, cosmetic, or food additive. It has not been evaluated by the FDA and is strictly prohibited from human or animal consumption, injection, or dosing.
Reviews
There are no reviews yet.